|
1
|
Ostrom QT, Patil N, Cioffi G, Waite K,
Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2013-2017. Neuro Oncol. 22:iv1–iv96. 2020.
View Article : Google Scholar
|
|
2
|
Stupp R, Taillibert S, Kanner A, Read W,
Steinberg D, Lhermitte B, Toms S, Idbaih A, Ahluwalia MS, Fink K,
et al: Effect of tumor-treating fields plus maintenance
temozolomide vs maintenance temozolomide alone on survival in
patients with glioblastoma: A randomized clinical trial. JAMA.
318:2306–2316. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ostrom QT, Rubin JB, Lathia JD, Berens ME
and Barnholtz-Sloan JS: Females have the survival advantage in
glioblastoma. Neuro Oncol. 20:576–577. 2018. View Article : Google Scholar
|
|
4
|
Yague JG, Lavaque E, Carretero J, Azcoitia
I and Garcia-Segura LM: Aromatase, the enzyme responsible for
estrogen biosynthesis, is expressed by human and rat glioblastomas.
Neurosci Lett. 368:279–284. 2004. View Article : Google Scholar
|
|
5
|
Dueñas Jiménez JM, Candanedo Arellano A,
Santerre A, Orozco Suárez S, Sandoval Sánchez H, Feria Romero I,
López-Elizalde R, Alonso Venegas M, Netel B, de la Torre Valdovinos
B and Dueñas Jiménez SH: Aromatase and estrogen receptor alpha mRNA
expression as prognostic biomarkers in patients with astrocytomas.
J Neurooncol. 119:275–284. 2014. View Article : Google Scholar
|
|
6
|
Prossnitz ER and Maggiolini M: Mechanisms
of estrogen signaling and gene expression via GPR30. Mol Cell
Endocrinol. 308:32–38. 2009. View Article : Google Scholar
|
|
7
|
Maggiolini M and Picard D: The unfolding
stories of GPR30, a new membrane-bound estrogen receptor. J
Endocrinol. 204:105–114. 2010. View Article : Google Scholar
|
|
8
|
Hsu LH, Chu NM, Lin YF and Kao SH:
G-protein coupled estrogen receptor in breast cancer. Int J Mol
Sci. 20:3062019. View Article : Google Scholar
|
|
9
|
Filardo EJ: Epidermal growth factor
receptor (EGFR) transactivation by estrogen via the
G-protein-coupled receptor, GPR30: A novel signaling pathway with
potential significance for breast cancer. J Steroid Biochem Mol
Biol. 80:231–238. 2002. View Article : Google Scholar
|
|
10
|
Vivacqua A, Bonofiglio D, Recchia AG,
Musti AM, Picard D, Andò S and Maggiolini M: The G protein-coupled
receptor GPR30 mediates the proliferative effects induced by
17beta-estradiol and hydroxytamoxifen in endometrial cancer cells.
Mol Endocrinol. 20:631–646. 2006. View Article : Google Scholar
|
|
11
|
Smith HO, Arias-Pulido H, Kuo DY, Howard
T, Qualls CR, Lee SJ, Verschraegen CF, Hathaway HJ, Joste NE and
Prossnitz ER: GPR30 predicts poor survival for ovarian cancer.
Gynecol Oncol. 114:465–471. 2009. View Article : Google Scholar
|
|
12
|
Tu G, Hu D, Yang G and Yu T: The
correlation between GPR30 and clinicopathologic variables in breast
carcinomas. Technol Cancer Res Treat. 8:231–234. 2009. View Article : Google Scholar
|
|
13
|
Bai LY, Weng JR, Hu JL, Wang D, Sargeant
AM and Chiu CF: G15, a GPR30 antagonist, induces apoptosis and
autophagy in human oral squamous carcinoma cells. Chem Biol
Interact. 206:375–384. 2013. View Article : Google Scholar
|
|
14
|
Yang DL, Xu JW, Zhu JG, Zhang YL, Xu JB,
Sun Q, Cao XN, Zuo WL, Xu RS, Huang JH, et al: Role of GPR30 in
estrogen-induced prostate epithelial apoptosis and benign prostatic
hyperplasia. Biochem Biophys Res Commun. 487:517–524. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu C, Liao Y, Fan S, Fu X, Xiong J, Zhou
S, Zou M and Wang J: G-protein-coupled estrogen receptor antagonist
G15 decreases estrogen-induced development of non-small cell lung
cancer. Oncol Res. 27:283–292. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Giakoumettis D, Kritis A and Foroglou N:
C6 cell line: The gold standard in glioma research. Hippokratia.
22:105–112. 2018.
|
|
17
|
Grobben B, De Deyn PP and Slegers H: Rat
C6 glioma as experimental model system for the study of
glioblastoma growth and invasion. Cell Tissue Res. 310:257–270.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu C, Liao Y, Fan S, Tang H, Jiang Z,
Zhou B, Xiong J, Zhou S, Zou M and Wang J: G protein-coupled
estrogen receptor (GPER) mediates NSCLC progression induced by
17β-estradiol (E2) and selective agonist G1. Med Oncol. 32:1042015.
View Article : Google Scholar
|
|
19
|
Irecta-Nájera CA, del Rosario Huizar-López
M, Casas-Solís J, Castro-Félix P and Santerre A: Protective effect
of lactobacillus casei on DMH-induced colon carcinogenesis
in mice. Probiotics Antimicrob Proteins. 9:163–171. 2017.
View Article : Google Scholar
|
|
20
|
Trejter M, Jopek K, Celichowski P,
Tyczewska M, Malendowicz LK and Rucinski M: Expression of estrogen,
estrogen related and androgen receptors in adrenal cortex of intact
adult male and female rats. Folia Histochem Cytobiol. 53:133–144.
2015. View Article : Google Scholar
|
|
21
|
Villalpando-Vargas F, Medina-Ceja L,
Santerre A and Enciso-Madero EA: The anticonvulsant effect of
sparteine on pentylenetetrazole-induced seizures in rats: A
behavioral, electroencephalographic, morphological and molecular
study. J Mol Histol. 51:503–518. 2020. View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Üçeyler N, Riediger N, Kafke W and Sommer
C: Differential gene expression of cytokines and neurotrophic
factors in nerve and skin of patients with peripheral neuropathies.
J Neurol. 262:203–212. 2015. View Article : Google Scholar
|
|
24
|
Castracani CC, Longhitano L, Distefano A,
Anfuso D, Kalampoka S, La Spina E, Astuto M, Avola R, Caruso M,
Nicolosi D, et al: Role of 17β-estradiol on cell proliferation and
mitochondrial fitness in glioblastoma cells. J Oncol.
2020:23146932020. View Article : Google Scholar
|
|
25
|
Molina L, Bustamante F, Ortloff A, Ramos
I, Ehrenfeld P and Figueroa CD: Continuous exposure of breast
cancer cells to tamoxifen upregulates GPER-1 and increases cell
proliferation. Front Endocrinol (Lausanne). 11:5631652020.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chevalier N, Vega A, Bouskine A, Siddeek
B, Michiels JF, Chevallier D and Fénichel P: GPR30, the
non-classical membrane G protein related estrogen receptor, is
overexpressed in human seminoma and promotes seminoma cell
proliferation. PLoS One. 7:e346722012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hirtz A, Lebourdais N, Rech F, Bailly Y,
Vaginay A, Smaïl-Tabbone M, Dubois-Pot-Schneider H and Dumond H:
GPER agonist G-1 disrupts tubulin dynamics and potentiates
temozolomide to impair glioblastoma cell proliferation. Cells.
10:34382021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bustos V, Nolan ÁM, Nijhuis A, Harvey H,
Parker A, Poulsom R, McBryan J, Thomas W, Silver A and Harvey BJ:
GPER mediates differential effects of estrogen on colon cancer cell
proliferation and migration under normoxic and hypoxic conditions.
Oncotarget. 8:84258–84275. 2017. View Article : Google Scholar
|
|
29
|
Ariazi EA, Brailoiu E, Yerrum S, Shupp HA,
Slifker MJ, Cunliffe HE, Black MA, Donato AL, Arterburn JB, Oprea
TI, et al: The G protein-coupled receptor GPR30 inhibits
proliferation of estrogen receptor-positive breast cancer cells.
Cancer Res. 70:1184–1194. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rajagopal S and Shenoy SK: GPCR
desensitization: Acute and prolonged phases. Cell Signal. 41:9–16.
2018. View Article : Google Scholar
|
|
31
|
Cheng S Bin, Quinn JA, Graeber CT and
Filardo EJ: Down-modulation of the G-protein-coupled estrogen
receptor, GPER, from the cell surface occurs via a
trans-Golgi-proteasome pathway. J Biol Chem. 286:22441–22455. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jean-Alphonse F and Hanyaloglu AC:
Regulation of GPCR signal networks via membrane trafficking. Mol
Cell Endocrinol. 331:205–214. 2011. View Article : Google Scholar
|
|
33
|
Wang C, Lv X, Jiang C and Davis JS: The
putative G-protein coupled estrogen receptor agonist G-1 suppresses
proliferation of ovarian and breast cancer cells in a
GPER-independent manner. Am J Transl Res. 4:390–402.
2012.PubMed/NCBI
|
|
34
|
Roque C, Mendes-Oliveira J and Baltazar G:
G protein-coupled estrogen receptor activates cell type-specific
signaling pathways in cortical cultures: Relevance to the selective
loss of astrocytes. J Neurochem. 149:27–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ulhaq ZS, Soraya GV, Milliana A and Tse
WKF: Association between GPER gene polymorphisms and GPER
expression levels with cancer predisposition and progression.
Heliyon. 7:e064282021. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Sjöström M, Hartman L, Grabau D, Fornander
T, Malmström P, Nordenskjöld B, Sgroi DC, Skoog L, Stål O,
Leeb-Lundberg LM and Fernö M: Lack of G protein-coupled estrogen
receptor (GPER) in the plasma membrane is associated with excellent
long-term prognosis in breast cancer. Breast Cancer Res Treat.
145:61–71. 2014. View Article : Google Scholar
|
|
37
|
Ino Y, Akimoto T, Takasawa A, Takasawa K,
Aoyama T, Ueda A, Ota M, Magara K, Tagami Y, Murata M, et al:
Elevated expression of G protein-coupled receptor 30 (GPR30) is
associated with poor prognosis in patients with uterine cervical
adenocarcinoma. Histol Histopathol. 35:351–359. 2020.
|
